PL193439A1 - Sposob wytwarzania nowych 6-arylo-s-triazolo/4,3-a/pirydo/2,3-f/-1,4-dwuazepin - Google Patents
Sposob wytwarzania nowych 6-arylo-s-triazolo/4,3-a/pirydo/2,3-f/-1,4-dwuazepinInfo
- Publication number
- PL193439A1 PL193439A1 PL19343976A PL19343976A PL193439A1 PL 193439 A1 PL193439 A1 PL 193439A1 PL 19343976 A PL19343976 A PL 19343976A PL 19343976 A PL19343976 A PL 19343976A PL 193439 A1 PL193439 A1 PL 193439A1
- Authority
- PL
- Poland
- Prior art keywords
- pirydo
- arylo
- triazolo
- pine
- double
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT837275A AT350056B (de) | 1975-11-04 | 1975-11-04 | Verfahren zur herstellung von neuen pyrido- (2,3-f)-(1,4)-diazepinen, deren optischen isomeren und salzen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL193439A1 true PL193439A1 (pl) | 1979-07-16 |
| PL113803B1 PL113803B1 (en) | 1981-01-31 |
Family
ID=3604891
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1976193439A PL113803B1 (en) | 1975-11-04 | 1976-11-03 | Process for preparing novel 6-aryl-s-triazolo-/4,3-a/-pyrido-/2,3-f/-1,4-diazepines |
| PL1976223070A PL118308B1 (en) | 1975-11-04 | 1976-11-03 | Process for preparing novel 6-aryl-s-triazolo/4,3-a/-pyrido/2,3-f/-1,4-diazepinesdo/2,3-ehf/-1,4-diazepinov |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1976223070A PL118308B1 (en) | 1975-11-04 | 1976-11-03 | Process for preparing novel 6-aryl-s-triazolo/4,3-a/-pyrido/2,3-f/-1,4-diazepinesdo/2,3-ehf/-1,4-diazepinov |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US4110455A (pl) |
| JP (1) | JPS5831351B2 (pl) |
| AR (3) | AR217814A1 (pl) |
| AT (1) | AT350056B (pl) |
| AU (1) | AU504228B2 (pl) |
| BE (1) | BE847952A (pl) |
| CA (1) | CA1076111A (pl) |
| CH (1) | CH630920A5 (pl) |
| CS (1) | CS191181B2 (pl) |
| DD (1) | DD128178A5 (pl) |
| DE (1) | DE2649116A1 (pl) |
| DK (1) | DK142324B (pl) |
| EG (1) | EG12280A (pl) |
| ES (2) | ES452969A1 (pl) |
| FI (1) | FI62088C (pl) |
| FR (1) | FR2330404A1 (pl) |
| GB (1) | GB1562800A (pl) |
| HU (1) | HU177422B (pl) |
| IL (1) | IL50816A (pl) |
| IN (1) | IN144289B (pl) |
| MX (1) | MX4284E (pl) |
| NL (1) | NL7612187A (pl) |
| NO (1) | NO146470C (pl) |
| PL (2) | PL113803B1 (pl) |
| PT (1) | PT65787B (pl) |
| RO (2) | RO77294A (pl) |
| SE (1) | SE7612260L (pl) |
| SU (2) | SU667137A3 (pl) |
| YU (1) | YU269176A (pl) |
| ZA (1) | ZA766620B (pl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1185601A (en) * | 1981-02-27 | 1985-04-16 | Walter Hunkeler | Imidazodiazepines |
| DE3435973A1 (de) * | 1984-10-01 | 1986-04-10 | Boehringer Ingelheim KG, 6507 Ingelheim | Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung |
| US4798896A (en) * | 1988-01-19 | 1989-01-17 | American Home Products Corporation | Antipsychotic gamma-carboline N-oxides |
| TW201201813A (en) | 2010-03-31 | 2012-01-16 | Arqule Inc | Substituted benzo-pyrido-triazolo-diazepine compounds |
| AR084070A1 (es) | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
| WO2012075456A1 (en) | 2010-12-02 | 2012-06-07 | Constellation Pharmaceuticals | Bromodomain inhibitors and uses thereof |
| US9422292B2 (en) | 2011-05-04 | 2016-08-23 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| WO2012174487A2 (en) | 2011-06-17 | 2012-12-20 | Constellation Pharmaceuticals, Inc. | Bromodomain inhibitors and uses thereof |
| TWI602820B (zh) | 2012-06-06 | 2017-10-21 | 星宿藥物公司 | 溴域抑制劑及其用途 |
| US9624244B2 (en) | 2012-06-06 | 2017-04-18 | Constellation Pharmaceuticals, Inc. | Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof |
| PL3157928T3 (pl) | 2014-06-20 | 2019-07-31 | Constellation Pharmaceuticals, Inc. | Krystaliczne postacie 2-((4S)-6-(4-chlorofenylo)-1-metylo-4H-benzo[ c]izoksazolo-[4,5-e]azepin-4-ylo)acetamidu |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT327917B (de) * | 1973-04-12 | 1976-02-25 | Degussa | Verfahren zur herstellung von neuen 5-aryl-pyrido- (b-6,7) -1,4-diazepinen und deren salzen |
| US4039551A (en) * | 1976-03-15 | 1977-08-02 | The Upjohn Company | 1-[(Hydroxyamino)methyl]-6-aryl-4H-s-triazolo[4,3-a][1,4]benzodiazepines |
-
1975
- 1975-11-04 AT AT837275A patent/AT350056B/de not_active IP Right Cessation
-
1976
- 1976-06-02 RO RO7697708A patent/RO77294A/ro unknown
- 1976-10-26 US US05/735,894 patent/US4110455A/en not_active Expired - Lifetime
- 1976-10-26 SU SU762414098A patent/SU667137A3/ru active
- 1976-10-27 FR FR7632326A patent/FR2330404A1/fr active Granted
- 1976-10-28 DE DE19762649116 patent/DE2649116A1/de not_active Withdrawn
- 1976-11-02 EG EG76673A patent/EG12280A/xx active
- 1976-11-02 DD DD7600195560A patent/DD128178A5/xx unknown
- 1976-11-02 GB GB45476/76A patent/GB1562800A/en not_active Expired
- 1976-11-02 YU YU02691/76A patent/YU269176A/xx unknown
- 1976-11-02 IL IL50816A patent/IL50816A/xx unknown
- 1976-11-03 AR AR265336A patent/AR217814A1/es active
- 1976-11-03 HU HU76DE927A patent/HU177422B/hu unknown
- 1976-11-03 RO RO7688309A patent/RO70245A/ro unknown
- 1976-11-03 PT PT65787A patent/PT65787B/pt unknown
- 1976-11-03 FI FI763158A patent/FI62088C/fi not_active IP Right Cessation
- 1976-11-03 NL NL7612187A patent/NL7612187A/xx not_active Application Discontinuation
- 1976-11-03 MX MX765041U patent/MX4284E/es unknown
- 1976-11-03 DK DK497076AA patent/DK142324B/da not_active IP Right Cessation
- 1976-11-03 BE BE6045743A patent/BE847952A/xx unknown
- 1976-11-03 PL PL1976193439A patent/PL113803B1/pl unknown
- 1976-11-03 CH CH1386976A patent/CH630920A5/de not_active IP Right Cessation
- 1976-11-03 ES ES452969A patent/ES452969A1/es not_active Expired
- 1976-11-03 PL PL1976223070A patent/PL118308B1/pl unknown
- 1976-11-03 ES ES452971A patent/ES452971A1/es not_active Expired
- 1976-11-03 CS CS767096A patent/CS191181B2/cs unknown
- 1976-11-03 SE SE7612260A patent/SE7612260L/xx not_active Application Discontinuation
- 1976-11-03 NO NO763739A patent/NO146470C/no unknown
- 1976-11-04 JP JP51132728A patent/JPS5831351B2/ja not_active Expired
- 1976-11-04 AU AU19311/76A patent/AU504228B2/en not_active Expired
- 1976-11-04 CA CA264,849A patent/CA1076111A/en not_active Expired
- 1976-11-04 ZA ZA766620A patent/ZA766620B/xx unknown
- 1976-11-17 IN IN2062/CAL/76A patent/IN144289B/en unknown
-
1977
- 1977-06-14 AR AR268053A patent/AR216916A1/es active
- 1977-06-14 AR AR268052A patent/AR216915A1/es active
- 1977-10-17 SU SU772532701A patent/SU676165A3/ru active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL193439A1 (pl) | Sposob wytwarzania nowych 6-arylo-s-triazolo/4,3-a/pirydo/2,3-f/-1,4-dwuazepin | |
| PL193761A1 (pl) | Sposob wytwarzania czteropierscieniowych chinonow | |
| TR19184A (tr) | Usul | |
| BG27547A3 (en) | Method of obtaining of 1,4- diphenyl- 3- pyrasoline- 5- ones | |
| PL192020A1 (pl) | Sposob wytwarzania n-tetrahydrofurfurylo-noroksymorfonow | |
| PL193861A1 (pl) | Sposob wytwarzania alfa-aminoketonow | |
| PL192253A1 (pl) | Sposob wytwarzania nowych pochodnych neaminy | |
| DK205176A (da) | Elektrolysemetode | |
| PL196122A1 (pl) | Sposob wytwarzania 2,9-dioksatricyklo/4,3,1,0 gora 3,gora 7/dekanow | |
| PL191209A1 (pl) | Sposob wytwarzania podstawionych 6-arylo-4h-s-triazolo-(3,4-c)-tieno-(2,3-e)i,4-dwuazepin | |
| PL191156A1 (pl) | Sposob wytwarzania nowych epoksyandrostanow | |
| JPS5226774A (en) | Method of making wood flyash | |
| PL100145B1 (pl) | Sposob wytwarzania nowych zwiazkow dwuureidowych | |
| SE7613545L (sv) | Sett att framstella difluormetyl-1,2,2-triflnoretyleter | |
| PL193604A1 (pl) | Sposob wytwarzania nowych d-homosteroidow | |
| SU534472A1 (ru) | Способ получени полиорганонитрилсилоксанов | |
| PL190303A1 (pl) | Sposob wytwarzania nowych enamin | |
| PL200287A1 (pl) | Sposob wytwarzania 2,5-dwuhydroksybenzenosulfonianow | |
| SU546665A1 (ru) | Способ получени хлорлигнина | |
| PL98360B1 (pl) | Sposob wytwarzania 1,1,1-trojchloro-2,2,2-trojfluoroetanu | |
| PL191945A1 (pl) | Sposob wytwarzania nowych 2,6-antrachinonylenoamidyn | |
| PL206390A1 (pl) | Sposob wytwarzania 2,4-dioksoheksahydro-1,3,5-triazyny | |
| PL191157A1 (pl) | Sposob wytwarzania nowego 5 alfa,17 beta-dwuacetoksy-6 beta-chloro-2 alfa,3 alfa,16 alfa,17 alfa-dwuepoksyandrostanu | |
| PL94833B1 (pl) | Sposob wytwarzania nowych 7-podstawionych 5,6,7,8-tetrahydropirydo-/3,4-d/-pirymidyn | |
| PL210915A1 (pl) | Sposob wytwarzania nowych tieno-(2,3-e)-triazolo-(3,4-c)-4,1-oksazepin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RECP | Rectifications of patent specification |